Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Cobra Biologics : Receives the Queen's Award for Enterprise in International Trade

04/21/2018 | 04:01am EST

The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy products.

Cobra Biologics (“Cobra”) a leading international contract development and manufacturing organisation (“CDMO”), today announced that it has been awarded the Queen’s Award 2018 for Enterprise, in the International Trade category. The prestigious award is in recognition of Cobra’s commercial success in providing services to its global customer base.

Now in their 53rd year, the Queen’s Awards have a long history of recognising exceptional UK businesses and Cobra will be attending a reception at Buckingham Palace followed by a presentation of the Award by a representative of Her Majesty The Queen at Cobra’s UK facility later in the year.

Cobra has a 20 year track record of supporting the life science industry with contract development and manufacturing of biopharmaceuticals, from preclinical through to clinical trials and commercial supply and currently exports over 85% of its services from its facilities based in the UK and Sweden.

Cobra’s UK based GMP approved facility is a globally recognised centre of excellence for the development and production of biological material to support both gene- and immuno-therapy. In April 2017, Cobra announced a £15 million gene therapy expansion plan, to meet the increased demand from both plasmid DNA and viral vectors for Phase III and Commercial supply to support both existing and new customer requirements in the development of revolutionary disease therapies.

Peter Coleman, Chief Executive of Cobra Biologics, commented: “I am immensely proud of what Cobra has achieved over the last few years, culminating in the Queen’s Award. International Trade is vitally important for Cobra and the work that we do is challenging and requires a committed work force whose skills and dedication attract business from all over the world. I would like also to thank the Office for Life Science, Innovate UK and the Department for International Trade for their support of our expansion plans in the UK.”

ENDS


ę Business Wire 2018
Latest news "Companies"
12/03London copper falls on fears of Sino-U.S. tensions, China inventory glut
RE
12/03China pares spot LNG purchases as high prices bite, inventories ample
RE
12/03INFOSYS : Disability groups call for national digital accessibility roadmap as new Infosys research reveals digital inclusion gap among Australian organisations
PU
12/03INFOSYS : New research from Infosys reveals a digital inclusion gap among New Zealand organisations
PU
12/03THAI UNION PUBLIC : recognized for Blue Finance Leadership at the Business+ Product of the Year Awards 2021
PU
12/03INDOOR SKYDIVE AUSTRALIA : Notification regarding unquoted securities - IDZ
PU
12/03INTRA ENERGY : Application for quotation of securities - IEC
PU
12/03THREAT PROTECT AUSTRALIA : AGM Presentation
PU
12/03ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
12/03Musk exercises more options, sells Tesla shares worth $1.01 bln
RE
Latest news "Companies"